Lotilaner Ophthalmic Solution 0.25%: First Approval

This article summarizes the milestones in the development of lotilaner ophthalmic solution 0.25% leading to this first approval for the treatment ofDemodex blepharitis in the USA.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research